Opinion on risk assessment report on 1,3,4,6,7,8-hexahydro-4,6,6,7,8,8-hexamethylcyclopenta-γ-2-benzopyran (HHCB), human health part (indirect exposure), SCHER/94/2008, (Adopted on 06 May 2008)